Literature DB >> 9370937

Identification of specific recognition molecules on murine mononuclear phagocytes and B lymphocytes for Vi capsular polysaccharide: modulation of MHC class II expression on stimulation with the polysaccharide.

A Qadri1.   

Abstract

Vi bacterial polysaccharide is a homopolymer of alpha 1-4 N-acetyl polygalacturonic acid with variable O-acetylation at position C-3 and forms a capsule around many bacteria. It has been referred to as the virulence factor of Salmonella typhi and is also a candidate vaccine against typhoid fever. The present study reports the interaction of this polysaccharide with murine mononuclear phagocytes and lymphocytes, and with human monocytes. Vi showed a dose-dependent binding to the murine monocyte cell lines WEHI-274.1 and J774. This binding was abrogated if the polysaccharide was deacetylated, suggesting involvement of acetyl groups in this interaction. Vi also bound to the murine B-cell lymphoma line A20, to peritoneal exudate cells and to a lesser degree to spleen cells and thymocytes from BALB/c mice. The polysaccharide also interacted with the human histiocytic lymphoma line U937 but not with the human monocyte cell line THP-1. Stimulation with Vi led to up-regulation of surface major histocompatibility complex (MHC) class II expression on A20 cells. Immunoprecipitation of Vi-bound molecules from cell surface biotinylated A20 and WEHI-274.1 revealed two bands with MW of about 32,000 and 36,000. The study demonstrates that Vi capsular polysaccharide can interact with mononuclear phagocytes and lymphocytes through specific cell surface molecules and modulate MHC class II expression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9370937      PMCID: PMC1363994          DOI: 10.1046/j.1365-2567.1997.00315.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  19 in total

1.  The VI antigens of the Enterobacteriaceae. I. Purification and chemical properties.

Authors:  E E BAKER; R E WHITESIDE; R BASCH; M A DEROW
Journal:  J Immunol       Date:  1959-12       Impact factor: 5.422

2.  Monoclonal antibodies against two discrete determinants on Vi capsular polysaccharide.

Authors:  A Qadri; S Ghosh; G P Talwar
Journal:  J Immunoassay       Date:  1990

Review 3.  Typhoid fever: pathogenesis and immunologic control.

Authors:  R B Hornick; S E Greisman; T E Woodward; H L DuPont; A T Dawkins; M J Snyder
Journal:  N Engl J Med       Date:  1970-09-24       Impact factor: 91.245

4.  Protective activity of Vi capsular polysaccharide vaccine against typhoid fever.

Authors:  K P Klugman; I T Gilbertson; H J Koornhof; J B Robbins; R Schneerson; D Schulz; M Cadoz; J Armand
Journal:  Lancet       Date:  1987-11-21       Impact factor: 79.321

5.  Immunological studies in typhoid fever. II. Cell-mediated immune responses and lymphocyte subpopulations in patients with typhoid fever.

Authors:  P Rajagopalan; R Kumar; A N Malaviya
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

6.  Establishment and characterization of a human histiocytic lymphoma cell line (U-937).

Authors:  C Sundström; K Nilsson
Journal:  Int J Cancer       Date:  1976-05-15       Impact factor: 7.396

7.  Characterization of the Salmonella paratyphi C Vi polysaccharide.

Authors:  E M Daniels; R Schneerson; W M Egan; S C Szu; J B Robbins
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

8.  Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report.

Authors:  I L Acharya; C U Lowe; R Thapa; V L Gurubacharya; M B Shrestha; M Cadoz; D Schulz; J Armand; D A Bryla; B Trollfors
Journal:  N Engl J Med       Date:  1987-10-29       Impact factor: 91.245

9.  Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animals.

Authors:  S C Szu; A L Stone; J D Robbins; R Schneerson; J B Robbins
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

10.  Immunochemical properties of Vi antigen from Salmonella typhi Ty2: presence of two antigenic determinants.

Authors:  B Szewczyk; A Taylor
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

View more
  3 in total

Review 1.  Capsule-mediated immune evasion: a new hypothesis explaining aspects of typhoid fever pathogenesis.

Authors:  Manuela Raffatellu; Daniela Chessa; R Paul Wilson; Cagla Tükel; Mustafa Akçelik; Andreas J Bäumler
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

2.  Interaction of Brucella abortus lipopolysaccharide with major histocompatibility complex class II molecules in B lymphocytes.

Authors:  C Forestier; E Moreno; S Méresse; A Phalipon; D Olive; P Sansonetti; J P Gorvel
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

3.  Vi polysaccharide of Salmonella typhi targets the prohibitin family of molecules in intestinal epithelial cells and suppresses early inflammatory responses.

Authors:  Amita Sharma; Ayub Qadri
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-02       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.